J. Koerts et al., OCCURRENCE OF THE NIH SHIFT UPON THE CYTOCHROME P450-CATALYZED IN-VIVO AND IN-VITRO AROMATIC RING HYDROXYLATION OF FLUOROBENZENES, Chemical research in toxicology, 11(5), 1998, pp. 503-512
The in vivo cytochrome P450-catalyzed aromatic hydroxylation of a seri
es of fluorobenzenes was investigated with special emphasis on the imp
ortance of the fluorine NIH shift. The results obtained demonstrate a
minor role for the NIH shift in the metabolism of the fluorobenzenes t
o phenolic metabolites in control male Wistar rats. These in vivo resu
lts could indicate that (1) the NIH shift is an inherently minor proce
ss for fluorine substituents or (2) it is a potentially significant pr
ocess but the presumed epoxide that leads to formation of the NIH-shif
ted metabolite is lost to an alternative metabolic pathway. In contras
t to the in vivo data, in vitro experiments showed a significant amoun
t of an NIH-shifted metabolite for 1,4-difluorobenzene. This result el
iminates the explanation that the NIH shift is an inherently minor pro
cess for fluorine substituents. Results of additional experiments pres
ented in this paper show that the reduced tendency of fluorine-substit
uted benzenes to undergo an NIH shift in vivo can-at least in part-be
ascribed to the possible existence of alternative pathways for metabol
ism of the epoxide, such as, for example, GSH conjugation, being more
efficient for fluorinated than chlorinated arene oxides.